Drug Reporting Requirements to Take Effect Feb. 26 Following Final Guidance

The FDA has finalized its 2021 draft version of a guidance that describes the timing and process of annual reporting of manufactured drugs, an effort intended to enhance the FDA’s visibility into drug supply chains.
Source: Drug Industry Daily